Valo Therapeutics Ltd Revenue and Competitors

Helsinki, FI

Location

$45M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Valo Therapeutics Ltd's estimated annual revenue is currently $3.6M per year.(i)
  • Valo Therapeutics Ltd's estimated revenue per employee is $155,000
  • Valo Therapeutics Ltd's total funding is $45M.

Employee Data

  • Valo Therapeutics Ltd has 23 Employees.(i)
  • Valo Therapeutics Ltd grew their employee count by -4% last year.

Valo Therapeutics Ltd's People

NameTitleEmail/Phone
1
VP Clinical Operations and Regulatory AffairsReveal Email/Phone
2
VP CMCReveal Email/Phone
3
VP Translational and Clinical Science, IP ManagerReveal Email/Phone
4
DirectorReveal Email/Phone
5
Business Operations DirectorReveal Email/Phone
6
Laboratory ManagerReveal Email/Phone
7
CSOReveal Email/Phone
8
Research And Development ScientistReveal Email/Phone
9
Senior ScientistReveal Email/Phone
10
Research Scientist IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M200%$3.49MN/A
#2
$3.7M24N/AN/AN/A
#3
$3.6M23-4%$45MN/A
Add Company

What Is Valo Therapeutics Ltd?

Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.

keywords:N/A

$45M

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M23-4%N/A
#2
$2.3M23N/AN/A
#3
$3.3M2335%N/A
#4
$2.3M23-18%N/A
#5
$2.4M24N/AN/A